University of Cambridge > Talks.cam > Darwin College Sciences Group > Genome sequencing paves the way for precision medicine in the NHS: the Pulmonary Arterial Hypertension (PAH) point of view

Genome sequencing paves the way for precision medicine in the NHS: the Pulmonary Arterial Hypertension (PAH) point of view

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Holly.

By definition a rare disease affects less than 5 in 10,000 people. An estimated 80% of these to date known 7,500 diesease are likely to have a genetic cause. Very often, however, an explanation at molecular level is missing. As part of the NIHR BioResource – Rare Diseases consortium, the pilot study of the Genomics England 100,000 genomes project, we sequenced the genomes of more than 13,000 patients diagnosed with one of 15 rare diseases. Examplified by pulmonary arterial hypertension, a rare form of high blood pressure measured in the arteries of lungs, I will take you on a brief journey from the blood sample through to a molecular diagnosis which can inform clinical decision making and lead to novel treatment.

This talk is part of the Darwin College Sciences Group series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2019 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity